Long-term cost-effectiveness of clopidogrel in patients with acute coronary syndrome without ST-segment elevation in Germany.

Brüggenjürgen, B; Lindgren, P; Ehlken, B; Rupprecht, H-J; Willich, S N

Brüggenjürgen, B; Lindgren, P; Ehlken, B; Rupprecht, H-J; Willich, S N.

Affiliation

Brüggenjürgen B; Institute for Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Germany. bernd.brueggenjuergen@charite.de

Eur J Health Econ ; 8(1): 51-7, 2007 Mar.

Article in En | MEDLINE | ID: mdl-17186199

Subject(s)

Acute Coronary Syndrome/drug therapy; Platelet Aggregation Inhibitors/economics; Platelet Aggregation Inhibitors/therapeutic use; Ticlopidine/analogs & derivatives; Acute Coronary Syndrome/complications; Acute Coronary Syndrome/mortality; Adult; Age Factors; Aged; Aspirin/economics; Aspirin/therapeutic use; Clopidogrel; Cost-Benefit Analysis; Electrocardiography; Female; Germany; Humans; Male; Markov Chains; Middle Aged; Models, Economic; Myocardial Infarction/prevention & control; Sex Factors; Ticlopidine/economics; Ticlopidine/therapeutic use

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ticlopidine / Platelet Aggregation Inhibitors / Acute Coronary Syndrome Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Eur J Health Econ Journal subject: SAUDE PUBLICA / SERVICOS DE SAUDE Year: 2007 Type: Article Affiliation country: Germany

Search on Google

XML

PubMed Links